Running further investigations, such as Willebrand factor-cleaving protease, also known as ADAMTS13, that would allow distinguishing thrombotic thrombocytopenic purpura from other thrombotic microangiopathies, was not feasible at that point. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.